Malaria vaccines: into a mirror, darkly?
Related Experiment Video
Updated: Jun 28, 2026

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
Magdalena Plebanski1, Emily Locke, James W Kazura
1Department of Immunology, Monash University, NHMRC Program on Malaria, VIC 3181, Australia. magdalena.plebanski@med.monash.edu.au
Abstract:
Recent advances in adjuvant and delivery systems, in addition to a wealth of genomic and proteomic information on parasite composition, are being harnessed to develop a malaria vaccine. To do so effectively, it might be necessary to reassess the criteria by which formulations have been selected to progress to clinical trials. Specifically, better in vitro surrogates of protective immunity, better animal models and a more complete understanding of the unique canvas presented by the immune system of individuals who have experienced multiple malaria infections are needed.
Related Concept Videos
Malaria
Symbiosis
Microorganisms in Medicine and Therapeutics

